Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)

• Company Description    MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. Number of Employees: 730

• Price / Volume Information    Yesterday's Closing Price: $78.50 Daily Weekly Monthly 20 Day Moving Average: 91,403 shares Shares Outstanding: 5.52 (millions) Market Capitalization: $433.50 (millions) Beta: 0.89 52 Week High: $155.12 52 Week Low: $55.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.75% 1.92% 12 Week 9.55% 7.78% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12100 W 6TH AVE - LAKEWOOD,CO 80228 USA ph: 303-987-8000 fax: 303-987-8989 investorrelations@mesalabs.com http://www.mesalabs.com

• General Corporate Information    Officers Gary M. Owens - Chief Executive Officer; President; and Director John J. Sullivan - Chairman of the Board of Directors John V. Sakys - Chief Financial Officer and Chief Accounting Offic Jennifer S. Alltoft - Director Mark C. Capone - Director Peer Information Mesa Laboratories, Inc. (ABMD) Mesa Laboratories, Inc. (DMDS) Mesa Laboratories, Inc. (CPWY.) Mesa Laboratories, Inc. (EQUR) Mesa Laboratories, Inc. (ECIA) Mesa Laboratories, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59064R109 SIC: 3823 Fiscal Year Fiscal Year End: March Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/03/26 Share - Related Items Shares Outstanding: 5.52 Most Recent Split Date: (:1) Beta: 0.89 Market Capitalization: $433.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.82% Current Fiscal Quarter EPS Consensus Estimate: $1.78 Indicated Annual Dividend: $0.64 Current Fiscal Year EPS Consensus Estimate: $7.26 Payout Ratio: 0.10 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 11/28/2025 - $0.16 Next EPS Report Date: 02/03/26

• Fundamental Ratios P/E Current FY Estimate: 10.81 Trailing 12 Months: 11.97 PEG Ratio: - Price Ratios Price/Book: 2.43 Price/Cash Flow: 6.40 Price / Sales: 1.77 EPS Growth vs. Year Ago Period: -32.60% vs. Previous Quarter: -24.69% Sales Growth vs. Year Ago Period: 5.02% vs. Previous Quarter: 2.01% ROE 12/31/25 - - 09/30/25 - 21.59 06/30/25 - 24.49 ROA 12/31/25 - - 09/30/25 - 8.28 06/30/25 - 9.03 Current Ratio 12/31/25 - - 09/30/25 - 2.02 06/30/25 - 0.66 Quick Ratio 12/31/25 - - 09/30/25 - 1.44 06/30/25 - 0.47 Operating Margin 12/31/25 - - 09/30/25 - 14.66 06/30/25 - 16.40 Net Margin 12/31/25 - - 09/30/25 - -0.64 06/30/25 - -0.26 Pre-Tax Margin 12/31/25 - - 09/30/25 - 2.96 06/30/25 - 3.74 Book Value 12/31/25 - - 09/30/25 - 32.32 06/30/25 - 31.35 Inventory Turnover 12/31/25 - - 09/30/25 - 3.40 06/30/25 - 3.30 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.95 06/30/25 - 0.46 Debt-to-Capital 12/31/25 - - 09/30/25 - 48.81 06/30/25 - 31.56

Powered by Zacks Investment Research ©